Airway Therapeutics, LLC reported raising $43.5 Million in an initial SEC Form D filing, from an offering of $50.6 Million
Amount Raised
$43.5 Million
Round Type
Series E
CincinnatiBiotechnologyHealth CareTherapeuticsInvestors
Description
Airway Therapeutics, Inc. announced a successful financing round of $50 million to support the late clinical development of Zelpultide alfa. The Series E-2 funding consists of $24 million raised and $26 million previously secured through a SAFE financing. The funds will primarily aid in completing Phase 2b/3 clinical studies and related activities
Who to call at Airway Therapeutics, LLC, and when
A new round usually means Airway Therapeutics, LLC is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Airway Therapeutics, LLC raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Airway Therapeutics, LLC, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Airway Therapeutics, LLC raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Airway Therapeutics, LLC raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.